Open AccessUpadacitinib in refractory ulcerative colitis
Author(s) -
Gabriel Rodríguez Toboso,
Pedro Ángel Rivera Vaquerizo,
María Nieves Martínez López,
María Del Mar Blasco Colmenarejo,
Félix Calvo Hernán,
Jose María Moreno Planas
Publication year - 2022
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.8870/2022
Subject(s) - medicine , ulcerative colitis , refractory (planetary science) , proctocolectomy , clinical practice , rescue therapy , colitis , gastroenterology , physical therapy , disease , physics , astrobiology
We report the first clinical-practice case to date of treatment with upadacitinib for ulcerative colitis, prior refractoriness to all therapeutic options, and preventing proctocolectomy as of today after treatment for 14 months.